SYMPOSIUM 3: Microglia role in neuropsychiatric disease and its potential as a treatment target

(chaired by Valeria Mondelli & Peter Talbot)   Given that clinical, genetic and pharmacological findings indicate that inflammatory molecules and their associated pathways are enhanced in neuropsychiatric disorders such as major depressive disorder and schizophrenia, Monday morning’s symposium 3 dealt with the importance of microglia cells in these disorders. Microglia are immune cells within the […]

Post-Doc Symposium 1: What can animal behaviours really tell us about human cognitive and emotional processes?

The amount of preclinical data being presented at the BAP Summer Meeting has been dwindling over the years, in favour of clinical and non-clinical human research.  This post-doctoral symposium was put together by myself and Dr Claire Hales from the University of Bristol to showcase preclinical work and to highlight the importance of using translational […]

SYMPOSIUM 9: Towards a mechanistic understanding of anxiety disorders: translational, pharmacological, neural and computational perspectives

Anxiety disorders are the most common mental illnesses in the UK, with important consequences as reduced quality of life, functional impairment and increased costs. However, current treatment has a moderate effect with 50-60% response rates. This symposium aimed to emphasize the need to understand the underlying biological mechanisms of anxiety disorders. All four speakers Oliver […]